In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy

por Craveiro, Rogerio B., Ehrhardt, Michael, Holst, Martin I., Pietsch, Thorsten, Dilloo, Dagmar
Publicado 2014

The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy

por Ehrhardt, Michael, Craveiro, Rogerio B., Holst, Martin I., Pietsch, Torsten, Dilloo, Dagmar
Publicado 2014